Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / oxycontin / ativan attending: chief complaint: chief complaint: shortness of breath reason for micu transfer: hypoxia major surgical or invasive procedure: none history of present illness: 71-year-old woman with a past medical history of known metastatic breast cancer and a known chronic pleural effusion (has bilateral drains, gets drained qod). over past two weeks she has had increased drainage. she presented to hospital with worsening shortness of breath. sat initially 75%. she was scheduled for pleuredesis here in the future. pt states increasing sob and increased drain output x 2 weeks, but acutely worse this week, with the output from the r-sided drain appearing more bloody. no fevers, chills, diarrhea, vomiting, abd pain. does note le edema bilaterally, as well as productive cough for the past week. denies recent sick contacts. she is undergoing chemo for breast ca (last session wednesday). in the ed, initial vs were: 98, 116/54, 97% 15l nrb. cxr initially with loculated effusions. ct of chest with worsened pleural effusion. ?distal pe on cta. satting 95% on nrb. on arrival to the micu, says that her breathing feels better but still feels sob. denies any cp, ha, abdom pain, leg pain. review of systems: per hpi past medical history: 1. cardiac risk factors: diabetes - , dyslipidemia - , hypertension - 2. other past medical history: bilateral stage i lobular carcinoma (see below) goiter, which is being followed basal cell cancer ten years ago . psh: tonsillectomy at age 14 and a cholecystectomy at age 25, rotator cuff surgery at 64 and knee surgery at age 55. . oncologic history: 1. : multiple suspicious areas on breast mri. bilateral breast biopsy demonstrated invasive lobular carcinoma. 2. : underwent bilateral mastectomy for what appeared to be multifocal disease in both breasts and had negative sentinel lymph node biopsy. the right breast had a lesion staged as t1b and was grade ii, er positive, pr negative, her-2 negative, grade ii. the left breast lesion was t1c m0, er/pr positive, her-2/neu negative without lymphovascular invasion and grade ii. brca testing negative. 3. : oncotype dx assay revealed a recurrence score of 21, which was in the intermediate risk group. the patient declined enrollment in the tailorx trial because she did not want chemotherapy. started on arimidex. the last bone mineral density scan in revealed osteopenia at the left femoral neck social history: lives with husband. 4 kids. occupation retired school teacher. smoking history 20 pack-year smoking hx; quit 33 years ago. alcohol denies. family history: a brother who was diagnosed with breast cancer at age 59, metastatic disease at age 60. she has a sister who was diagnosed with breast cancer at age 49 and died at age 51 from metastatic disease. she has another sister recently diagnosed with breast cancer in . genetic testing for brca 1 or 2 mutations was performed and was negative. physical exam: admission physical exam: vitals: t 98.1 hr 95 bp 107/44 rr 27 o2 93% nrb general: alert, oriented, no acute distress, can speak in full sentences heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl neck: supple, jvp not elevated, no lad cv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs, gallops. pulsus measured at about . lungs: clear to auscultation b/l in upper lung fields; decreased air movement halfway up lung fields, dullness to percussion, bronchial breath sounds, rubs, and coarse ronchi in b/l lower lung fields. abdomen: soft, non-distended, bowel sounds present, no organomegaly, no tenderness to palpation, no rebound or guarding. b/l chest tube sites with clean dressings. gu: no foley ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema discharge exam - expired pertinent results: admission labs: 11:15pm blood wbc-7.2 rbc-3.59* hgb-10.6* hct-34.1* mcv-95 mch-29.7 mchc-31.1 rdw-18.3* plt ct-410 11:15pm blood neuts-78.9* lymphs-18.0 monos-2.2 eos-0.5 baso-0.4 11:15pm blood pt-11.5 ptt-27.3 inr(pt)-1.1 11:15pm blood glucose-96 urean-14 creat-0.9 na-133 k-4.8 cl-100 hco3-22 angap-16 11:15pm blood probnp-1349* 11:15pm blood ctropnt-<0.01 05:05am blood ck-mb-1 ctropnt-<0.01 11:15pm blood calcium-8.4 phos-4.0 mg-2.0 11:36pm blood lactate-1.5 discharge labs: 04:23am blood wbc-10.4 rbc-3.60* hgb-10.9* hct-33.5* mcv-93 mch-30.2 mchc-32.5 rdw-17.6* plt ct-486* 04:23am blood pt-13.5* ptt-25.6 inr(pt)-1.3* 02:53pm blood glucose-154* urean-22* creat-1.1 na-125* k-5.0 cl-95* hco3-19* angap-16 04:23am blood calcium-8.0* phos-3.5 mg-1.8 micro: -bcx - ngtd -sputum - yeast and commensal respiratory flora -pleural fluid - no growth imaging: -cxr (admission, ): increased moderate loculated right and small dependent left pleural effusions with accompanying mild pulmonary edema. infectious process in the right lobe would be difficult to exclude. -cxr (most recent, ): compared to the most recent radiograph from , moderate right apical pneumothorax accompanying passive collapse of underlying lung has minimally increased whereas minimal right basal pneumothorax is smaller. bilateral, diffuse, pulmonary edema is constant. left port-a-catheter tip is in low svc. a singel chest tube is presenting in right lung base. left lung base opacity improved over last 24 hours is mostly atelectasis. -tte (): the left atrium is normal in size. left ventricular wall thickness, cavity size, and global systolic function are normal (lvef>55%). due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. there is no ventricular septal defect. the right ventricular cavity is mildly dilated with normal free wall contractility. the mitral valve leaflets are mildly thickened. mild (1+) mitral regurgitation is seen. the tricuspid valve leaflets are mildly thickened. tricuspid regurgitation is present but cannot be quantified. there is mild pulmonary artery systolic hypertension. there is a very small pericardial effusion. there are no echocardiographic signs of tamponade. -cta chest (): 1. interval increase in large loculated right and small dependent left pleural effusions with resultant increase in consolidation in the right lung, most of which is likely compressive atelectasis. 2. bilateral left greater than right ground-glass opacity with septal thickening is most likely pulmonary edema, though in this patient on chemotherapy accompanying atypical infection would be difficult to exclude. progression of metastatic disease is felt less likely given the time course. 3. tiny left apical subsegmental pulmonary embolus of questionable clinical significance. 4. stable mediastinal and hilar metastatic disease -lenis (): no evidence of dvt in bilateral lower extremities. brief hospital course: ms. is a 71-year-old woman with h/o metastatic breast cancer and known chronic pleural effusion (has bilateral pleurex catheters, gets drained qod), who p/w 2 weeks of worsening sob and hypoxia. she had persistent hypoxia and a trapped right lung, for which further intervention could not be undertaken. during this hospitalization, she made a transition to defer further aggressive treatment or diagnostics and was transitioned to comfort measures. she was initially admitted to the icu, however after her decision to focus on comfort was transferred to the floor on a morphine drip. she passed away soon after her transition to the floor in the presence of her husband and family. active issues: # sob and hypoxia: this was likely due to an increase in her malignant effusions, as well as trapped right lung. she does have notable h/o recurrent bilateral malignant pleural effusions with bilateral pleurx catheters - s/p right sided pleurx on and left sided pleurx on . interventional pulmonary (ip) was consulted and recommended 2 doses tpa to the r catheter. the improved fluid drainage after the loculations were broken up, however the right lung remained trapped and did not reexpand after fluid removal. she was also found to have a pna (had new ggo's on ct chest), and was treated with vanc, cefepime and azithro which was subsequently changes to levofloxacin. per ip, there was no further intervention possible for her trapped lung, as well as ptx and loculations. # goals of care and symptom control: given her metastatic disease and trapped right lung refractory to medical interventions, the decision was made to pursue comfort-focused care after a family meeting. efforts were made to transition the patient to hospice, but she worsened clinically prior to transfer and care was transitioned to comfort. she was placed on a morphine gtt on . chronic/inactive issues: # metastatic breast ca: at admission, pt on weekly taxol 80mg/m2 c3d12. we continued morphine as needed for pain. given her goals of care as discussed above, anastrozole was discontinued prior to discharge. # rue dvt: diagnosed in early during hospital admission in setting of recent picc line; plan was for lifelong anticoagulation. lovenox was discontinued in the setting of comfort focused care. # afib/flutter: occurred during pericardial window. amiodarone was discontinued prior to discharge as this may have been contributing to her nausea. medications on admission: medications - prescription amiodarone - 200 mg tablet - 1 (one) tablet(s) by mouth once daily anastrozole - 1 mg tablet - 1 tablet(s) by mouth daily enoxaparin - 60 mg/0.6 ml syringe - injection subcutaneously twice a day (every twelve hours) lidocaine - 5 % (700 mg/patch) adhesive patch, medicated - apply at 8pm up to twice daily patch may remain in place for up to 12 hours. remove at 8am. morphine - 15 mg tablet extended release - 1 tablet(s) by mouth every 12 hours ondansetron hcl - 4 mg tablet - 1 (one) tablet(s) by mouth every eight (8) hours as needed for nausea oxycodone - 5 mg tablet - 1 tablet(s) by mouth every 6 hours pantoprazole - 20 mg tablet, delayed release (e.c.) - 1 tablet(s) by mouth once a day as needed for may repeat once - no substitution sertraline - 25 mg tablet - 1 tablet(s) by mouth daily medications - otc docusate sodium - (otc) - 100 mg capsule - capsule(s) by mouth twice daily glucosamine &chondroit-mv-min3 - (prescribed by other provider; otc) - dosage uncertain multivitamin - (prescribed by other provider) - dosage uncertain polyethylene glycol 3350 - (otc) - 17 gram/dose powder - by mouth discharge medications: patient expired discharge disposition: expired discharge diagnosis: primary diagnosis loculated pleural effusion with trapped lung pneumothorax bacterial pneumonia secondary diagnosis metastatic breast cancer discharge condition: patient expired discharge instructions: patient expired followup instructions: patient expired procedure: injection or infusion of thrombolytic agent injection or infusion of thrombolytic agent thoracentesis diagnoses: pneumonia, organism unspecified other pulmonary insufficiency, not elsewhere classified hyposmolality and/or hyponatremia atrial fibrillation personal history of malignant neoplasm of breast atrial flutter personal history of other malignant neoplasm of skin personal history of venous thrombosis and embolism encounter for palliative care do not resuscitate status goiter, unspecified malignant pleural effusion other pneumothorax 

Answer: The patient is high likely exposed to